Pomerantz Law Firm Investigating Claims on Behalf of Investors in IDEXX Laboratories, Inc.
Share This Story
NEW YORK, Feb. 4, 2010 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of IDEXX Laboratories, Inc. ("IDEXX" or the "Company") .
IDEXX is a developer, manufacturer and distributor of products for veterinary, and food and water testing markets. On January 29, the Company disclosed an investigation by the Federal Trade Commission into possible violations of Section 5 of the FTC act. Specifically the Commission is "conducting an investigation to determine whether IDEXX is engaging in unfair competition through pricing marketing policies for Companion Animals products or services ("CAG")". The CAG segment provides point-of-care veterinary diagnostic products, such as instruments and consumables, and rapid assays; and information products and services, and digital radiography systems for veterinarians. This segment also offers commercial veterinary reference laboratory and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, and South Africa. After the disclosure of the investigation, IDEXX fell $5.48, or 9.4%.
Those who invested are advised to contact Teresa Webb at 888-476-6529 or 212-661-1100 or tlwebb@pomlaw.com. Pomerantz has prosecuted securities fraud claims for 70 years, and is regarded as one of the country's premier class action firms. The firm has offices in New York City, Chicago, Washington, D.C., Burlingame, CA and Columbus, Ohio.
Search News
